Introdução: A doença por coronavírus 2019 (COVID-19) aumentou a pressão assistencial sobre os hospitais. Para contenção da transmissão foram adotadas medidas alternativas de prestação de cuidados às doenças crónicas nomeadamente através do recurso à Telemedicina. A satisfação dos doentes face aos cuidados recebidos associa-se a um melhor prognóstico. Com este estudo pretende-se avaliar a satisfação com os cuidados prestados na consulta telefónica de Medicina Interna. Material e Métodos: Após revisão bibliográfica foi criado um questionário para avaliação da satisfação dos doentes com a consulta telefónica. Foram incluídos todos os doentes que tiveram consulta telefónica de Medicina Interna em Setembro de 2020. O questionário foi aplicado ao próprio doente ou familiar. Resultados: O questionário foi realizado a 81 doentes com idade média de 67,9 anos e predomínio do género masculino (53,1%). O questionário foi respondido pelo próprio doente em 71,6% dos casos. Setenta doentes (86,5%) concordam/ concordam totalmente que a consulta telefónica permitiu ter os cuidados de saúde que necessitavam e 88,8% concorda/ concorda totalmente que é uma forma aceitável de receber cuidados de saúde. A maioria (74,1%) revelou estar satisfeita com a consulta telefónica. Discussão e Conclusão: Apresentamos um novo questionário de satisfação que revelou ter uma boa fiabilidade podendo ser uma importante ferramenta para o futuro. Em geral os doentes atribuíram altos scores totais de satisfação à consulta telefónica, traduzindo-se na sua aceitação como forma alternativa de receber cuidados de saúde. A implementação da Telemedicina durante a atual pandemia permite manter os cuidados de saúde revelando-se uma estratégia promissora.
La amiloidosis es una enfermedad poco frecuente, de etiología desconocida, caracterizada por la presencia de depósitos extracelulares de proteínas fibrilares en diversos órganos y tejidos, teniendo una amplia gama de manifestaciones clínicas según localización y tamaño de los depósitos. En cabeza y cuello, el sitio de presentación más frecuente es la laringe. Suele presentarse con disfonía y/o disnea progresiva, cuyo tratamiento definitivo, sin estar estandarizado, suele ser la resección quirúrgica. Se presenta a continuación el caso de un paciente de 78 años, con historia de disnea en reposo y estridor laríngeo leve de 6 meses de evolución, cuya nasofibroscopía evidenció una masa subglótica, determinando lumen crítico de vía aérea superior. Biopsia reveló amiloidosis, siendo tratado de manera exitosa con exéresis tumoral vía laringoscopía directa.
Introduction The patients with Pulmonary Thromboembolism (PE) stratified as intermediate-high risk with the European Society of Cardiology classification represent an heterogenous population, with the majority having a benign outcome however some evolving in clinical deterioration. Several risk scores have been developed to try and refine the population most at risk but they are deemed sub-optimal. Purpose Our aim was to assess the capacity of the National Early Warning Score (NEWS) in predicting a composite end-point of 30-days cardiovascular mortality, rescue thombolysis and/or haemodynamic instability, in a population of intermediate-high risk PE, as compared with other risk evaluation scores as the PESI and SHIeLD scores. Methods We performed a retrospective analysis between 2014 and 2019 of all patients admitted for intermediate-high risk PE, in a single expert centre. The patients who underwent fibrinolysis as per clinician discretion (without haemodynamically instability or clinical evidence of clinical deterioration) were excluded. Medical records were analysed for clinical data and outcomes. The predictive accuracy of all scores were assessed using the area under curve (AUC) of receiver operating characteristics (ROC) curve. The association between NEWS and composite end-point at 30-days was analyzed using a Cox regression model. Results Of the 1132 patients assessed and admitted with PE, 116 patients fulfilled all inclusion criteria and none of the exclusion criteria and were analysed. The mean age was 69±16 years at time of diagnosis with a female preponderance (62.9%). Most patients were treated with anticoagulation (97.4%), 68% with low molecular weight heparin and the remaining with unfractionated heparin. The average NEWS score was 7±3, the average PESI score was 110±34 and the average SHIeLD score was 14±13. A primary composite end-point occurred in 18 patients (15.5%). The NEWS score showed the greatest predictive power for the occurrence of an event (OR 1.35; 95% CI 1.11–1.64, p=0.003) compared with the SHIeLD score (OR 1.0; 95% CI 1.00–1.07, p=0.035) and the PESI score (OR 1.02; 95% CI 1.00–1.03, p=0.03); it also showed a greatest discriminative capacity with the ROC curve analysis (Figure 1A) demonstrating an AUC of 0.70, vs 0.65 and 0.62 respectively. The survival analysis demonstrated a Hazard Ratio of 1.29 (95% CI 1.10–1.52; p=0.002) signifying a 29% increased risk of an event per each NEWS class increase, with the Kaplan Meier curves widening significantly in the different terciles of the score (Figure 1B). Conclusions In PE patients with intermediate-high risk the NEWS score demonstrated a greater predictive power and discriminative capacity than other commonly used risk scores. The NEWS score may help to identify patients in this risk category who might benefit from a reperfusion strategy, but larger studies are needed to confirm this hypothesis. Funding Acknowledgement Type of funding sources: None.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.